Annual Report

Overview

The report presents SOTAC Pharmaceuticals Limited's FY2023-24 standalone and consolidated results, including consolidated revenue from operations of Rs. 10,383.05 Lakh. It reports 68 employees at March 31, 2024 and states that the company is building a diverse and inclusive workforce. CSR spending of Rs. 9,31,417 supported vocational training, rural development and livelihood promotion, while nil sexual-harassment complaints were reported. Its energy disclosure says no alternate energy source was adopted and no specific energy-conservation investment was made.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2023-2024
Period: 1 April 2023 – 31 March 2024
Language: English
Pages
File size
Restatement: Disclosed

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services